Global Community

Nu Holdings takes a hit as Brazil’s economy weakens and loan losses rise, but the core idea stays the same: a branch-free bank that keeps gaining customers and selling them more services. The next chapters—getting bigger in Mexico, testing new AI-driven advice, and a possible move into the U.S.—could change how investors see the business, but there are real risks tied to Brazil and credit quality.Read more

Some investors worry that new AI design tools will weaken Adobe, but this view argues the threat is getting more attention than it deserves. The case is that Adobe stays the go-to choice for creative and marketing work, and the business keeps turning sales into reliable cash even as competition grows.Read more

Overview of Saudi Electricity Company (Tadawul: 5110) utilizing updated financial data up to mid-2026, here is a comprehensive breakdown of the company's fundamental and technical position. P/E Ratio: 14.5x (Based on operating profits, considering net income volatility due to the Mudaraba instrument).Read more

IDP Education looks deeply out of favour as governments tighten rules for international students, but the business still manages to raise prices even while fewer students apply. The big question is whether this is a temporary policy slump that can fade, or a lasting hit from new rivals and tougher visa settings.Read more

By: The Forensic Analyst | Simply Wall St In the chaotic world of equity markets, price and value often diverge. But rarely do they divorce as violently as we are currently seeing with Ubisoft Entertainment SA (UBI.PA).Read more

Tempus AI isn't simply an AI software business (not another ChatBot). It's building a healthcare data platform where diagnostics, genomic testing, clinical data, and AI applications reinforce each other through a powerful network effect.Read more

Tanco Holdings is hit by a sudden wave of selling, but that drop may be bringing it back to price areas where buyers previously stepped in. A near-term share index addition could also draw fresh attention, making the next few weeks a key test of whether the stock can steady itself or keep sliding.Read more

One-line thesis A capital-light, cash-generative multi-brand franchisor trading at ~3x EV/EBITDA and a ~30% normalised FCF yield, priced by the market for permanent ~6% annual decline — when the actual setup is a confirmed coffee-margin tailwind, an accelerating cost-out, and a near-term earnings inflection. The catch, and the reason it's cheap, is a single-lender balance sheet with negative tangible equity and an August 2027 refinancing wall.Read more

Overview P/E: 15.67 RSI: 42 (Reflects the stock approaching relatively oversold areas due to the recent decline). Dividend Yield: 3.28% What is their moat: The company's economic moat consists of two main barriers: the massive capital cost of infrastructure (hospitals costing hundreds of millions) which prevents new competitors from easily entering the market, and the "network advantage" with its deep integration with major insurance companies, alongside regulatory complexities and Ministry of Health licensing.Read more